Drugs that contain Aliskiren Hemifumarate; Hydrochlorothiazide

1. List of Tekturna Hct drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023893 NODEN PHARMA Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Mar, 2022

(11 months ago)

US8618172 NODEN PHARMA Galenical formulations of organic compounds
Jul, 2028

(5 years from now)

Market Authorisation Date: 18 January, 2008

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of TEKTURNA HCT before it's patent expiration?
More Information on Dosage

TEKTURNA HCT family patents

12

European Union

7

Korea, Republic of

7

Japan

7

New Zealand

6

United States

5

Spain

5

China

3

Hong Kong

3

Australia

3

Poland

3

Germany

3

Israel

3

Slovenia

3

Portugal

3

Russia

3

Norway

3

Canada

3

Denmark

2

Austria

2

Brazil

2

Luxembourg

2

Netherlands

2

Mexico

2

Hungary

2

United Kingdom

2

South Africa

2

Peru

2

Czech Republic

2

Ecuador

1

Morocco

1

Chile

1

Malaysia

1

Guatemala

1

Slovakia

1

Cyprus

1

Tunisia

1

Argentina

1

Singapore

1

Taiwan, Province of China

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic